Sign In to Follow Application
View All Documents & Correspondence

Composition Exhibiting Astringent Properties

Abstract: The present disclosure discloses an astringent composition comprising Sapindus mukorossi extract; and at least one magnesium salt, wherein the Sapindus mukorossi extract to the at least one magnesium salt is present in specific weight ratio range. The composition of the present disclosure prevents moisture loss from epidermis and exhibits antiperspirant properties. Also provided is a method of preparing the composition.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
22 March 2019
Publication Number
39/2020
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
iprdel@lakshmisri.com
Parent Application
Patent Number
Legal Status
Grant Date
2023-09-14
Renewal Date

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase -1, Bangalore Karnataka 560 058, India

Inventors

1. CHAVAN, Milind Abaji
ITC LIFE SCIENCES AND TECHNOLOGY CENTRE #3, 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058, India
2. KALSI, Gurpreet
ITC LIFE SCIENCES AND TECHNOLOGY CENTRE #3, 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058, India

Specification

I/We Claim;
1) An astringent composition comprising:
(a) Sapindus mukorossi extract; and
(b) at least one magnesium salt,
wherein the Sapindus mukorossi extract to the at least one magnesium salt weight ratio is in the range of 4:1 to 0.40:1.
2) The astringent composition as claimed in claim 1, wherein the Sapindus mukorossi extract to the at least one magnesium salt weight ratio is in a range of 4:1 to 0.60:1.
3) The astringent composition as claimed in claim 1, wherein the at least one magnesium salt is selected from magnesium sulfate, magnesium chloride, or combinations thereof.
4) The astringent composition as claimed in claim 1, wherein the Sapindus mukorossi extract comprises saponin having a weight percentage in a range of 30 - 45 % with respect to the Sapindus mukorossi extract.
5) The astringent composition as claimed in claim 1, wherein Sapindus mukorossi extract has a weight percentage in a range of 0.2 to 0.9 % with respect to the composition.
6) The astringent composition as claimed in claim 1, wherein the at least one magnesium salt has a weight percentage in a range of 0.1 - 0.7 % with respect to the composition.
7) The astringent composition as claimed in claim 1, further comprises at least one cosmetically acceptable excipient.
8) A process for preparing the astringent composition, the process comprising:

(a) obtaining Sapindus mukorossi extract;
(b) obtaining at least one magnesium salt; and
(c) contacting Sapindus mukorossi extract, and the at least one magnesium salt to obtain the astringent composition.
9) A process for preparing the astringent composition as claimed in claim 7, the
process comprising:
(a) obtaining Sapindus mukorossi extract;
3n

(b) obtaining at least one magnesium salt;
(c) obtaining the at least one cosmetically acceptable excipient, and contacting Sapindus mukorossi extract, the at least one magnesium salt, and the cosmetically acceptable excipient to obtain the astringent composition.
10) A formulation for prevention of moisture loss from epidermis, comprising the astringent composition as claimed in any one of the claims 1-7.

Documents

Application Documents

# Name Date
1 201941011122-STATEMENT OF UNDERTAKING (FORM 3) [22-03-2019(online)].pdf 2019-03-22
2 201941011122-REQUEST FOR EXAMINATION (FORM-18) [22-03-2019(online)].pdf 2019-03-22
3 201941011122-FORM 18 [22-03-2019(online)].pdf 2019-03-22
4 201941011122-FORM 1 [22-03-2019(online)].pdf 2019-03-22
5 201941011122-DRAWINGS [22-03-2019(online)].pdf 2019-03-22
6 201941011122-DECLARATION OF INVENTORSHIP (FORM 5) [22-03-2019(online)].pdf 2019-03-22
7 201941011122-COMPLETE SPECIFICATION [22-03-2019(online)].pdf 2019-03-22
8 201941011122-Proof of Right (MANDATORY) [22-04-2019(online)].pdf 2019-04-22
9 201941011122-FORM-26 [22-04-2019(online)].pdf 2019-04-22
10 Correspondence by Agent_Form 26_24-04-2019.pdf 2019-04-24
11 Correspondence by Agent_Form 1-Proof of Right_24-04-2019.pdf 2019-04-24
12 201941011122-FER.pdf 2021-10-17
13 201941011122-FER_SER_REPLY [28-03-2022(online)].pdf 2022-03-28
14 201941011122-US(14)-HearingNotice-(HearingDate-21-08-2023).pdf 2023-07-21
15 201941011122-FORM-26 [18-08-2023(online)].pdf 2023-08-18
16 201941011122-Correspondence to notify the Controller [18-08-2023(online)].pdf 2023-08-18
17 201941011122-US(14)-ExtendedHearingNotice-(HearingDate-28-08-2023).pdf 2023-08-21
18 201941011122-Correspondence to notify the Controller [25-08-2023(online)].pdf 2023-08-25
19 201941011122-Written submissions and relevant documents [06-09-2023(online)].pdf 2023-09-06
20 201941011122-PatentCertificate14-09-2023.pdf 2023-09-14
21 201941011122-IntimationOfGrant14-09-2023.pdf 2023-09-14

Search Strategy

1 11searchstrgyE_23-09-2021.pdf

ERegister / Renewals

3rd: 06 Dec 2023

From 22/03/2021 - To 22/03/2022

4th: 06 Dec 2023

From 22/03/2022 - To 22/03/2023

5th: 06 Dec 2023

From 22/03/2023 - To 22/03/2024

6th: 06 Dec 2023

From 22/03/2024 - To 22/03/2025

7th: 21 Mar 2025

From 22/03/2025 - To 22/03/2026